您好,欢迎访问中国农业科学院 机构知识库!

Novel technologies are turning a dream into reality: conditionally replicating viruses as vaccines

文献类型: 外文期刊

作者: Tang, Yan-Dong 1 ; Yu, Changqing 2 ; Cai, Xue-Hui 1 ;

作者机构: 1.Chinese Acad Agr Sci, State Key Lab Anim Dis Control & Prevent, Harbin Vet Res Inst, Harbin, Peoples R China

2.Yibin Vocat & Tech Coll, Engn Ctr Agr Biosafety Assessment & Biotechnol, Sch Adv Agr Sci, Yibin, Peoples R China

3.Heilongjiang Prov Res Ctr Vet Biomed, Harbin, Peoples R China

4.Heilongjiang Prov Key Lab Vet Immunol, Harbin, Peoples R China

期刊名称:TRENDS IN MICROBIOLOGY ( 影响因子:15.9; 五年影响因子:18.6 )

ISSN: 0966-842X

年卷期: 2024 年 32 卷 3 期

页码:

收录情况: SCI

摘要: Conditionally replicating viruses (CRVs) are a type of virus with one or more essential gene functions that are impaired resulting in the disruption of viral genome replication, protein synthesis, or virus particle assembly. CRVs can replicate only if the deficient essential genes are supplied. CRVs are widely used in biomedical research, particularly as vaccines. Traditionally, CRVs are generated by creating complementary cell lines that provide the impaired genes. With the development of biotechnology, novel techniques have been invented to generate CRVs, such as targeted protein degradation (TPD) technologies and premature termination codon (PTC) read-through technologies. The advantages and disadvantages of these novel technologies are discussed. Finally, we provide perspectives on what challenges need to be overcome for CRVs to reach the market.

  • 相关文献
作者其他论文 更多>>